SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

SAN

82.47

+0.33%↑

MRK1

119.85

+0.76%↑

SHL.DE

44.33

-0.87%↓

ARGX

734

+1.1%↑

FRE

48.33

+0.86%↑

Inicio・Lista de Acciones・RHOEN-KLINIKUM AG

RHOEN-KLINIKUM AG

Cerrado

12.6 2.44

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

11.8

Máximo

12.6

Métricas clave
By Trading Economics
Ingresos	2.9M 9.9M
Ventas	9.8M 429M
P/B Media del Sector	22.456 76.798
BPA	0.148
Rentabilidad por dividendo	0.78
Margen de beneficio	2.317
Empleados	19,041
EBITDA	1M 27M

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	0.78% 2.37%

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	54M 857M
Apertura anterior	10.16
Cierre anterior	12.6

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

N/A / 15.2 Soporte y Resistencia

RHOEN-KLINIKUM AG Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

18 dic 2025, 23:54 UTC

Acciones populares

Stocks to Watch: Nike, Cassava Sciences, KB Home

18 dic 2025, 23:51 UTC

Ganancias

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18 dic 2025, 23:39 UTC

Principales Movimientos del Mercado

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18 dic 2025, 22:57 UTC

Adquisiciones, fusiones, absorciones

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18 dic 2025, 21:40 UTC

Ganancias

Nike Sales Tick Up, But China Weakness Persists

18 dic 2025, 23:45 UTC

Charlas de Mercado

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18 dic 2025, 23:37 UTC

Charlas de Mercado

Ganancias

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18 dic 2025, 23:36 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18 dic 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18 dic 2025, 23:02 UTC

Adquisiciones, fusiones, absorciones

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18 dic 2025, 23:00 UTC

Adquisiciones, fusiones, absorciones

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18 dic 2025, 22:59 UTC

Adquisiciones, fusiones, absorciones

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18 dic 2025, 22:58 UTC

Adquisiciones, fusiones, absorciones

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18 dic 2025, 22:57 UTC

Adquisiciones, fusiones, absorciones

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18 dic 2025, 22:56 UTC

Adquisiciones, fusiones, absorciones

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18 dic 2025, 22:55 UTC

Ganancias

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dic 2025, 21:59 UTC

Ganancias

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dic 2025, 21:50 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

18 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

18 dic 2025, 21:35 UTC

Ganancias

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18 dic 2025, 21:31 UTC

Ganancias

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q Greater China Rev Down 17% >NKE

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q EPS 53c >NKE

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q Apparel Rev $3.91B >NKE

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q Equipment Rev $550M >NKE

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q N Amer Rev $5.63B >NKE

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q Footwear Rev $7.66B >NKE

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18 dic 2025, 21:15 UTC

Ganancias

Nike 2Q Greater China Rev $1.42B >NKE

Comparación entre iguales

Cambio de precio

RHOEN-KLINIKUM AG Esperado

Consenso

By TipRanks

0 ratings

Comprar

Mantener

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para RHOEN-KLINIKUM AG Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

N/A / 15.2Soporte y Resistencia

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de RHOEN-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.